Denali Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 801k | 14.52 |
| 2025-06-30 | $11M | 791k | 13.99 |
| 2025-03-31 | $15M | 1.1M | 13.60 |
| 2024-12-31 | $25M | 1.2M | 20.38 |
| 2024-09-30 | $39M | 1.3M | 29.13 |
| 2024-06-30 | $36M | 1.5M | 23.22 |
| 2024-03-31 | $37M | 1.8M | 20.52 |
| 2023-12-31 | $40M | 1.9M | 21.46 |
| 2023-09-30 | $41M | 2.0M | 20.63 |
| 2023-06-30 | $59M | 2.0M | 29.51 |
| 2023-03-31 | $47M | 2.0M | 23.04 |
| 2022-12-31 | $56M | 2.0M | 27.81 |
| 2022-09-30 | $57M | 1.9M | 30.14 |
| 2022-06-30 | $55M | 1.9M | 29.43 |
| 2022-03-31 | $52M | 1.6M | 32.17 |
| 2021-12-31 | $0 | 933k | 0.00 |
| 2021-09-30 | $19M | 377k | 50.47 |
| 2021-06-30 | $27M | 347k | 78.44 |
| 2021-03-31 | $15M | 261k | 57.10 |
| 2020-12-31 | $37M | 439k | 83.76 |
| 2020-09-30 | $26M | 728k | 35.83 |
| 2020-06-30 | $16M | 646k | 24.18 |
| 2020-03-31 | $6.0M | 344k | 17.51 |
| 2019-12-31 | $5.9M | 336k | 17.42 |
| 2019-09-30 | $5.2M | 339k | 15.32 |
| 2019-06-30 | $4.7M | 227k | 20.76 |
| 2019-03-31 | $5.3M | 228k | 23.22 |
| 2018-12-31 | $4.7M | 228k | 20.66 |
| 2018-09-30 | $4.4M | 204k | 21.74 |
| 2018-06-30 | $934k | 61k | 15.26 |
| 2018-03-31 | $1.0M | 52k | 19.69 |